AHCC09

AHCC09	A multi-national, double-blind, placebo-controlled, parallel randomized arms, phase II trial to compare the safety and efficacy of SIRT-Y90 followed by atezolizumab plus bevacizumab versus SIRT-Y90 followed by placebo in patients with locally advanced hepatocellular carcinoma (HCC) (STRATUM) (NCT05377034)
Status	Recruiting
Contributing Principal Investigators and Centres	Singapore Pierce Chow (National Cancer Centre), Toh Han Chong (National Cancer Centre), Chee Cheng Ean (National University Hospital) up to 11 overseas sites from: Taiwan (TBC) South Korea (TBC) China (TBC)
Protocol Chair	Pierce Chow pierce.chow@duke-nus.edu.sg

AHCC09

A multi-national, double-blind, placebo-controlled, parallel randomized arms, phase II trial to compare the safety and efficacy of SIRT-Y90 followed by atezolizumab plus bevacizumab versus SIRT-Y90 followed by placebo in patients with locally advanced hepatocellular carcinoma (HCC) (STRATUM) (NCT05377034)

Status

Recruiting

Contributing Principal Investigators and Centres

Singapore

Pierce Chow (National Cancer Centre), Toh Han Chong (National Cancer Centre), Chee Cheng Ean (National University Hospital)

up to 11 overseas sites from:

Taiwan (TBC)

South Korea (TBC)

China (TBC)

Protocol Chair

Pierce Chow
pierce.chow@duke-nus.edu.sg